Comparison of the performance of rapid prescreening, 10% random review, and clinical risk criteria as methods of internal quality control in cervical cytopathology

Cancer

Volumn 114, Issue 3, 2008, Pages 165-170

  Tavares, Suelene B N ^a   Alves De Sousa, Nadja L ^a   Manrique, Edna J C ^a   Pinheiro De Albuquerque, Zair B ^a   Zeferino, Luiz C ^b   Amaral, Rita G ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

10 random review; Cervical cytology; False negative rate; Internal quality control; Rapid prescreening; Review based on clinical risk criteria; Sensitivity

Indexed keywords

ARTICLE; CYTOPATHOLOGY; FALSE NEGATIVE RESULT; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; QUALITY CONTROL; RISK FACTOR; SCREENING; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

CYTOLOGICAL TECHNIQUES; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; QUALITY CONTROL; RANDOM ALLOCATION; SENSITIVITY AND SPECIFICITY; VAGINAL SMEARS;

EID: 47049114865     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23509     Document Type: Article

References (31)

1. Guimaraes E, Silva AM. Errors in cytopathologic gynecology: why do they occur [in Portugese]? J Bras Ginec. 1995;105:397-404.
2. Morin C, Bairati I, Bouchard C, et al. Cytologic predictors of cervical intraepithelial neoplasia in women with an ASCUS Pap smear. Acta Cytol. 2000;44:576-586.
3. Ortiz-Vazquez G, Duarte-Torres R, Cortez-Ortega RH, et al. Rapid rescreening as internal quality control in cervical cytology. Personal proficiency testing of the laboratory personnel [in Spanish]. Rev Med Hosp Gen Mex. 2001;64:6-10.
4. DeMay RM. Common problems in Papanicolaou smear interpretation. Arch Pathol Lab Med. 1997;121:229-238.
5. Mattosinho de Castro FMG, Dall' Agnol M, di Loreto C, et al. One hundred percent rapid rescreening for quality assurance in a quality control program in a public health cytologic laboratory. Acta Cytol. 2005;49:639-643.
6. di Loreto C, Maeda MYS, Utagawa ML, Longatto Filho A, Alves VAF. Quality assurance in cytopathology: aspects of the cytohistological correlation [in Portugese]. Rev Assoc Med Bras. 1997;43:195-198.
7. Doornewaard H, van de Seijp H, Woudt JM, van der Graaf Y, van den Tweel JG. Negative cervical smears before CIN 3/carcinoma. Reevaluation with the PAPNET testing system. Acta Cytol. 1997;41:74-78.
8. Bergeron C, Masseroli M, Ghezi A, Lemarie A, Mango L, Koss LG. Quality control of cervical cytology in high-risk women. PAPNET system compared with manual rescreening. Acta Cytol. 2000;44:151-157.
9. Rowe LR, Marshall CJ, Bentz JS. One hundred percent thorough quality control rescreening of liquid-based monolayers in cervicovaginal cytopathology. Cancer (Cancer Cytopathol). 2002;96:325-329.
10. Gay JD, Donaldson LD, Goellner JR. False-negative results in cervical cytologic studies. Acta Cytol. 1985;29:1043-1046.
11. Renshaw AA. Analysis of error in calculating the false-negative rate in the interpretation of cervicovaginal smears: the need to review abnormal cases. Cancer (Cancer Cytopathol). 1997;81:264-271.
12. Ferenczy A, Franco E. Cervical-cancer screening beyond the year 2000. Lancet Oncol. 2001;2:27-32.
13. Pittoli JE, Mello ES, Pereira SMM, et al. Review of previous negative smears from patients with high grade intraepithelial neoplasia [in Portugese]. J Bras Patol Med Lab. 2003;39:219-221.
14. Pajtler M, Audy-Jurkovic S, Skopljanac-Macina L, Antulov J, Barisic A, Milicic-Juhas V. Rapid cervicovaginal smear screening: method of quality control and assessing individual cytotechnologist performance. Cytopathology. 2006;17:121-126.
15. Centers for Disease Control. Regulations for implementing the Clinical Laboratory Improvement Amendments of 1988: a summary. JAMA. 1992;267:1725-1734.
16. Melamed MR. Rescreening for quality control in cytology [editorial]. Acta Cytol. 1996;40:12-13.
17. Tabbara SO, Sidawy MK. Evaluation of the 10% rescreen of negative gynecologic smears as a quality assurance measure. Diagn Cytopathol. 1996;14:84-86.
18. Dudding N, Hewer EM, Lancucki L, Rice S. Rapid screening: a comparative study. Cytopathology. 2001;12:235-248.
19. Amaral RG, Zeferino LC, Hardy E, Westin MC, Martinez EZ, Montemor EB. Quality assurance in cervical smears: 100% rapid rescreening versus 10% random rescreening. Acta Cytol. 2005;49:244-248.
20. Renshaw AA. Lezon KM, Wilbur DC. The human false-negative rate of rescreening Pap smears measured in a 2 arm prospective clinical trial. Cancer (Cancer Cytopathol). 2001;93:103-110.
21. Hutchinson ML. Assessing the costs and benefits of alternative rescreening strategies [editorial]. Acta Cytol. 1996;40:4-8.
22. Mulligan NJ, Morenas A, Soto-Wright V, O'Brien MJ. Percentages of cervical cytologic diagnosis as a quality assurance method. Acta Cytol. 1998;42:928-932.
23. Manrique EJ, Amaral RG, Alves de Souza NL, Tavares SdB, Pinheiro de Albuquerque ZB, Zeferino LC. Evaluation of 100% rescreening of negative cervical smears as a quality assurance measure. Cytopathology. 2006;17:116-120.
24. Arbyn M, Schenck U, Ellison E, Hanselaar A. Meta-analysis of the accuracy of rapid prescreening relative to full screening of Papanicolaou smears. Cancer (Cancer Cytopathol). 2003;99:9-16.
25. Renshaw AA. Rescreening in cervical cytology for quality control. When bad data are worse than no data or what works, what doesn't, and why. Clin Lab Med. 2003;23:695-708.
26. Smith J, Nicholas D, Boyd K, Deacon-Smith R. Rapid prescreening: a validated quality assurance measure in cervical cytology. Cytopathology. 2003;14:275-280.
27. Djemli A, Khetani K, Auger M. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy. Cancer (Cancer Cytopathol). 2006;108:21-26.
28. Michelow P, Mckee G, Hlongwane F. Rapid rescreening of cervical smears as a quality control method in a high-risk population. Cytopathology. 2006;17:110-115.
29. Solomon D, Nayar R. The Bethesda System for Reporting Cervical Cytology. New York, NY: Springer-Verlag; 2004.
30. Renshaw AA. Comments on "Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy." Cancer (Cancer Cytopathol). 2006;108:267-268.
31. Farrell DJ, Bilkhu S, Gibson LM, Cummings L, Wadehra V. Rapid screening of cervical smears as a method of internal quality control. For how long should we rescreen? Acta Cytol. 1997;41:251-260.